Roivant Sciences Ltd (NASDAQ: ROIV) – Suitable For Long Term Buy?
Currently, there are 695.94M common shares owned by the public and among those 418.04M shares have been available to trade. The company’s stock has a 5-day price change of 4.15% and 6.56% over the past three months. ROIV shares are trading 6.85% year to date (YTD), with the 12-month market performance down to -2.45% lower. […]
Roivant Sciences Ltd (NASDAQ: ROIV) Loses -14.90% From High. Why That Could Change?
Currently, there are 695.94M common shares owned by the public and among those 418.04M shares have been available to trade. The company’s stock has a 5-day price change of -2.29% and 3.73% over the past three months. ROIV shares are trading -6.09% year to date (YTD), with the 12-month market performance up to 2.78% higher. […]
Roivant Sciences Ltd (ROIV): Not A Time To Panic Nor Freeze
Roivant Sciences Ltd (ROIV) concluded trading on Thursday at a closing price of $11.47, with 3.99 million shares of worth about $45.71 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -6.14% during that period and on June 12, 2025 the price saw a […]
Roivant Sciences Ltd (NASDAQ: ROIV): Stock That Needs Special Handling
Currently, there are 695.94M common shares owned by the public and among those 417.69M shares have been available to trade. The company’s stock has a 5-day price change of 2.76% and 9.83% over the past three months. ROIV shares are trading -5.58% year to date (YTD), with the 12-month market performance up to 4.10% higher. […]
Roivant Sciences Ltd (ROIV): Insights At A Glance
Roivant Sciences Ltd (ROIV) concluded trading on Wednesday at a closing price of $10.62, with 6.3 million shares of worth about $66.96 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -10.15% during that period and on Wednesday the price saw a loss of […]
Growth Story Still Intact For Roivant Sciences Ltd (ROIV)
Roivant Sciences Ltd (ROIV) concluded trading on Thursday at a closing price of $10.76, with 3.78 million shares of worth about $40.64 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -8.89% during that period and on May 15, 2025 the price saw a […]
Roivant Sciences Ltd (NASDAQ: ROIV) Is Getting Increasingly Hard To Ignore
Currently, there are 719.63M common shares owned by the public and among those 438.55M shares have been available to trade. The company’s stock has a 5-day price change of -2.04% and 2.03% over the past three months. ROIV shares are trading -6.51% year to date (YTD), with the 12-month market performance down to -1.60% lower. […]
Roivant Sciences Ltd (NASDAQ: ROIV) Is Getting Increasingly Hard To Ignore
Currently, there are 719.63M common shares owned by the public and among those 438.55M shares have been available to trade. The company’s stock has a 5-day price change of 11.45% and 0.45% over the past three months. ROIV shares are trading -5.41% year to date (YTD), with the 12-month market performance up to 2.66% higher. […]
Do Roivant Sciences Ltd (NASDAQ: ROIV) Fit In A Value Investing Philosophy?
Currently, there are 719.63M common shares owned by the public and among those 438.67M shares have been available to trade. The company’s stock has a 5-day price change of 2.26% and -7.54% over the past three months. ROIV shares are trading -11.92% year to date (YTD), with the 12-month market performance up to 0.58% higher. […]
Set Your Sights On Roivant Sciences Ltd (NASDAQ: ROIV)’S Upside Potential
Roivant Sciences Ltd (ROIV) concluded trading on Thursady at a closing price of $11.36, with 5.08 million shares of worth about $57.69 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 1.88% during that period and on Thursady the price saw a loss of […]